By Melissa Lipman ( August 31, 2012, 6:29 PM EDT) -- Upsher-Smith Laboratories Inc. on Wednesday became the second defendant to ask the U.S. Supreme Court to review the Third Circuit's ruling that pay-for-delay pharmaceutical patent settlements are presumptively anti-competitive, telling the justices that the time is finally right to consider the issue....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.